Unnamed: 0,title,date,stock,sentiment
1072820.0,"Benzinga's Top Upgrades, Downgrades For May 13, 2020",2020-05-13 09:58:00-04:00,RDUS,positive
1072821.0,"Morgan Stanley Downgrades Radius Health to Equal-Weight, Announces $20 Price Target",2020-05-13 06:20:00-04:00,RDUS,neutral
1072822.0,"JP Morgan Maintains Overweight on Radius Health, Lowers Price Target to $27",2020-05-12 11:09:00-04:00,RDUS,negative
1072823.0,"Radius Health Q1 Adj. EPS $(0.590) Beats $(0.690) Estimate, Sales $47.923M Beat $46.260M Estimate",2020-05-07 17:21:00-04:00,RDUS,neutral
1072824.0,"Radius Health Reports Pres, CEO Jesper Hoeiland To Step Down; Names Kelly Martin Replacement",2020-04-28 16:36:00-04:00,RDUS,neutral
1072825.0,"Benzinga's Top Upgrades, Downgrades For April 24, 2020",2020-04-24 09:38:00-04:00,RDUS,positive
1072826.0,"Stifel Initiates Coverage On Radius Health with Hold Rating, Announces Price Target to $20",2020-04-24 05:56:00-04:00,RDUS,neutral
1072827.0,"Morgan Stanley Maintains Overweight on Radius Health, Lowers Price Target to $32",2020-04-15 10:51:00-04:00,RDUS,negative
1072828.0,"The Daily Biotech Pulse: Setback For DBV In Peanut Allergy Patch Review, Roche Starts Coronavirus Test Shipment, Regeneron Aims For 'Cocktail' COVID-19 Treatment",2020-03-17 08:48:00-04:00,RDUS,neutral
1072829.0,"The Daily Biotech Pulse: Roche Obtains FDA Emergency Use Authorization For COVID-19 Test, Chembio Appoints New CEO, Inovio Slumps On Earnings",2020-03-13 07:52:00-04:00,RDUS,negative
1072830.0,Stocks That Hit 52-Week Lows On Thursday,2020-03-12 12:10:00-04:00,RDUS,negative
1072831.0,"The Daily Biotech Pulse: NY State Endorses Mallinckrodt's Opioid Settlement, Kamada To Work On COVID-19 Treatment",2020-03-11 08:03:00-04:00,RDUS,positive
1072832.0,Stocks That Hit 52-Week Lows On Tuesday,2020-03-10 10:37:00-04:00,RDUS,negative
1072833.0,"The Daily Biotech Pulse: Mesoblast To Test Candidate On Coronavirus Symptoms, Proxy Battle Ahead For Rockwell Medical, Glaukos to Join S&P SmallCap 600 Index",2020-03-10 09:19:00-04:00,RDUS,negative
1072834.0,"Morgan Stanley Maintains Overweight on Radius Health, Lowers Price Target to $33",2020-03-06 09:36:00-05:00,RDUS,negative
1072835.0,"H.C. Wainwright Maintains Neutral on Radius Health, Raises Price Target to $28",2020-02-28 09:35:00-05:00,RDUS,neutral
1072836.0,"The Daily Biotech Pulse: Sangamo In Genome-Editing Therapy Deal With Biogen, FDA Nod For Biohaven, Passage Bio IPO",2020-02-28 07:28:00-05:00,RDUS,neutral
1072837.0,140 Biggest Movers From Yesterday,2020-02-28 05:00:00-05:00,RDUS,neutral
1072838.0,Stocks That Hit 52-Week Lows On Thursday,2020-02-27 10:23:00-05:00,RDUS,negative
1072839.0,"Radius Health Q4 Adj. EPS $(0.29) Beats $(0.77) Estimate, Sales $55.665M Beat $53.29M Estimate",2020-02-27 08:07:00-05:00,RDUS,neutral
1072840.0,"The Daily Biotech Pulse: Gilead Kicks Off Coronavirus Drug Trials, Adcom Nod For Lily, FDA Approves Esperion's Lipid-Lowering Adjunctive Combo Therapy",2020-02-27 07:35:00-05:00,RDUS,positive
1072841.0,The Week Ahead In Biotech: Biopharma Earnings Pick Up Pace,2020-02-23 18:38:00-05:00,RDUS,neutral
1072842.0,85 Biggest Movers From Yesterday,2020-02-04 04:56:00-05:00,RDUS,neutral
1072843.0,61 Stocks Moving In Monday's Mid-Day Session,2020-02-03 12:25:00-05:00,RDUS,neutral
1072844.0,"Radius Expects FY20 TYMLOS Sales $220M-$235M, Sees Cash Burn Below $80B",2020-01-13 09:06:00-05:00,RDUS,neutral
1072845.0,8 Biotech Stocks Morgan Stanley Recommends For 2020,2019-12-17 18:27:00-05:00,RDUS,positive
1072846.0,"Morgan Stanley Maintains Overweight on Radius Health, Lowers Price Target to $36",2019-11-13 08:14:00-05:00,RDUS,negative
1072847.0,60 Biggest Movers From Yesterday,2019-11-07 05:44:00-05:00,RDUS,neutral
1072848.0,62 Stocks Moving In Wednesday's Mid-Day Session,2019-11-06 13:48:00-05:00,RDUS,neutral
1072849.0,"Radius Health Q3 EPS $(0.65) Beats $(0.82) Estimate, Sales $46.77M Beat $45.69M Estimate",2019-11-05 16:25:00-05:00,RDUS,neutral
1072850.0,38 Biggest Movers From Yesterday,2019-10-08 05:39:00-04:00,RDUS,neutral
1072851.0,30 Stocks Moving In Monday's Mid-Day Session,2019-10-07 12:32:00-04:00,RDUS,neutral
1072852.0,Biotech Stock On The Radar: FDA Verdict Ahead For Pfenex's Osteoporosis Biosimilar,2019-10-03 15:49:00-04:00,RDUS,positive
1072853.0,"The Daily Biotech Pulse: NewLink Genetics Rallies, Breakthrough Designation For Roche, IGM Biosciences Debuts",2019-09-18 07:39:00-04:00,RDUS,neutral
1072854.0,Stocks That Hit 52-Week Highs On Tuesday,2019-09-17 10:40:00-04:00,RDUS,neutral
1072855.0,Stocks That Hit 52-Week Highs On Friday,2019-09-13 14:58:00-04:00,RDUS,neutral
1072856.0,"The Daily Biotech Pulse: All Eyes On Aimmune, Ritter Stumbles In Late-Stage Study, Catalyst Shelves Offering Plans",2019-09-13 07:40:00-04:00,RDUS,neutral
1072857.0,"The Daily Biotech Pulse: Genmab-Novartis Multiple Sclerosis Drug Aces Late-Stage Studies, Akari Nets Orphan Drug Designation",2019-08-30 08:28:00-04:00,RDUS,neutral
1072858.0,Stocks That Hit 52-Week Highs On Thursday,2019-08-29 10:15:00-04:00,RDUS,neutral
1072859.0,23 Healthcare Stocks Moving In Thursday's Pre-Market Session,2019-08-29 08:40:00-04:00,RDUS,neutral
1072860.0,"Citigroup Upgrades Radius Health to Buy, Raises Price Target to $40",2019-08-29 07:22:00-04:00,RDUS,neutral
1072861.0,Radius Health Option Alert: Sep 20 $25 Calls Sweep (33) near the Ask: 522 @ $0.7 vs 1148 OI; Ref=$22.82,2019-08-20 13:24:00-04:00,RDUS,positive
1072862.0,"Citi Assumes Radius Health at Neutral, Announces $24 Price Target",2019-05-30 09:10:00-04:00,RDUS,neutral
1072863.0,10 Biggest Price Target Changes For Wednesday,2019-05-29 09:41:00-04:00,RDUS,neutral
1072864.0,"Benzinga's Top Upgrades, Downgrades For May 29, 2019",2019-05-29 09:26:00-04:00,RDUS,positive
1072865.0,"Goldman Sachs Upgrades Radius Health to Buy, Raises Price Target to $38 Price Target",2019-05-29 07:00:00-04:00,RDUS,neutral
1072866.0,"The Daily Biotech Pulse: Daiichi's Positive Breast Cancer Trial, Supernus Slumps, Axovant Reverse Split",2019-05-08 07:53:00-04:00,RDUS,negative
1072867.0,Radius Health Presents Analysis from Phase 3 ACTIVE Trial and Data from Preclinical Studies for TYMLOS Injection at #ENDO2019,2019-03-23 19:41:00-04:00,RDUS,positive
1072868.0,Radius Health To Present Data On TYMLOS Injection At ENDO 2019 Annual Meeting,2019-03-18 08:01:00-04:00,RDUS,neutral
1072869.0,Radius Health Reaffirms FY19 TYMLOS Net Sales Guidance Of $155M-$175M,2019-02-28 17:45:00-05:00,RDUS,neutral
1072870.0,"Radius Health Q4 EPS $(0.66) Beats $(1.17) Estimate, Sales $34.424M Beat $32.01M Estimate",2019-02-28 17:43:00-05:00,RDUS,neutral
1072871.0,"The Daily Biotech Pulse: Bristol-Myers Squibb-Celgene Deal Faces Setback, Syneos Hit By SEC Probe, FDA Cheer For T2 Biosystems",2019-02-28 08:24:00-05:00,RDUS,positive
1072872.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings, IPOs",2019-02-22 13:55:00-05:00,RDUS,neutral
1072873.0,"H.C. Wainwright Initiates Coverage On Radius Health with Neutral Rating, Announces $22 Price Target",2019-02-14 07:31:00-05:00,RDUS,neutral
1072874.0,"Radius Health, Inc. Reports FY18 TYMLOS Sales Above Guidance Range Of $95M-$98M",2019-01-07 09:24:00-05:00,RDUS,neutral
1072875.0,24 Stocks Moving In Thursday's Pre-Market Session,2018-12-20 08:03:00-05:00,RDUS,neutral
1072876.0,"Radius Health Offers Updates On Oncology Programs: Says Phase 3 Elacestrant Study Open For Enrollment, Won Fast Track Designation, Pre-Clinical Data Showed Further Evidence Of Anti-Tumor Activity, RAD140 Phase 1 Study Continues To Enroll Patients",2018-11-30 09:02:00-05:00,RDUS,positive
1072877.0,"The Daily Biotech Pulse: FDA Nod For Mallinckrodt's Pain Drug, AbbVie-Neurocrine Report Positive Elagolix Results",2018-11-15 08:10:00-05:00,RDUS,positive
1072878.0,"The Daily Biotech Pulse: Viking's Fatty Liver And Cholesterol Drug, Cyclacel Loss Narrows, Eton's Debut",2018-11-13 07:54:00-05:00,RDUS,negative
1072879.0,"Stocks Which Set New 52-Week Low Yesterday, October 31st",2018-11-01 10:37:00-04:00,RDUS,negative
1072880.0,"Radius Health Q3 EPS $(0.85) Beats $(1.27) Estimate, Sales $27.639M Beat $26.06M Estimate",2018-11-01 08:48:00-04:00,RDUS,neutral
1072881.0,"The Daily Biotech Pulse: AbbVie's Leukemia Drug Trial Meets Endpoint, Denali Strikes Collaboration Deal",2018-11-01 07:30:00-04:00,RDUS,negative
1072882.0,"Stocks Which Set New 52-Week Low Yesterday, October 29th",2018-10-30 12:40:00-04:00,RDUS,negative
1072883.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Results And IPOs",2018-09-23 16:10:00-04:00,RDUS,neutral
1072884.0,"Stocks Which Set New 52-Week Low Yesterday, September 17th",2018-09-18 09:27:00-04:00,RDUS,negative
1072885.0,"The Daily Biotech Pulse: Morphosys Expands Collaboration, Osiris Announces Product Launch, Argenx To Offer Shares",2018-09-18 08:44:00-04:00,RDUS,positive
1072886.0,"Stocks Which Set New 52-Week Low Friday, September 14",2018-09-17 09:30:00-04:00,RDUS,negative
1072887.0,"The Week Ahead In Biotech (Sept. 16-22): Conferences, PDUFA Dates, Clinical Trial Results And IPOs",2018-09-16 14:22:00-04:00,RDUS,neutral
1072888.0,"Stocks Which Set New 52-Week Low Yesterday, September 13th",2018-09-14 09:30:00-04:00,RDUS,negative
1072889.0,"Stocks Which Set New 52-Week Low Friday, September 7th",2018-09-10 16:38:00-04:00,RDUS,negative
1072890.0,Radius Health Names Charles Morris Chief Medical Officer,2018-09-04 09:17:00-04:00,RDUS,neutral
1072891.0,Radius Health Amended 13D From MPM Bioventures Shows Liquidated 9.5% Stake,2018-08-30 16:29:00-04:00,RDUS,neutral
1072892.0,"Radius Health 10%+ Owner BB Biotech AG Buys 60,000 @ Avg Price: $19.65",2018-08-22 11:10:00-04:00,RDUS,neutral
1072893.0,"Stocks Which Set New 52-Week Low Yesterday, August 15th",2018-08-16 11:15:00-04:00,RDUS,negative
1072894.0,"Stocks Which Set New 52-Week Low Yesterday, August 14th",2018-08-15 12:34:00-04:00,RDUS,negative
1072895.0,"Radius Health Option Alert: Jan, 2020 $20 Calls at the Ask: 743 @ $6.3 vs 40 OI; Ref=$21.17",2018-08-13 14:59:00-04:00,RDUS,positive
1072896.0,"Stocks Which Set New 52-Week Low Yesterday, August 9th",2018-08-10 10:05:00-04:00,RDUS,negative
1072897.0,"The Daily Biotech Pulse: FDA Snub For Gemphire, Ligand Earnings, Insmed's Antibiotic Faces FDA Panel",2018-08-07 08:23:00-04:00,RDUS,negative
1072898.0,"Radius Health Q2 EPS $(1.52) Misses $(1.35) Estimate, Sales $22.629M Beat $20.46M Estimate",2018-08-07 07:46:00-04:00,RDUS,negative
1072899.0,"Stocks Which Set New 52-Week Low Yesterday, August 2nd",2018-08-03 11:22:00-04:00,RDUS,negative
1072900.0,"The Daily Biotech Pulse: Zafgen Executive Departs; Adamas, Acceleron Accelerate On Earnings",2018-08-03 07:52:00-04:00,RDUS,neutral
1072901.0,"Stocks Which Set New 52-Week Low Yesterday, August 1st",2018-08-02 11:07:00-04:00,RDUS,negative
1072902.0,"The Daily Biotech Pulse: Denali's Parkinson's Candidate Clears Early-Stage Trials, Dexcom's Strong Quarter",2018-08-02 08:54:00-04:00,RDUS,positive
1072903.0,"Stocks Which Set New 52-Week Low Yesterday, July 31",2018-08-01 12:16:00-04:00,RDUS,negative
1072904.0,"Benzinga's Biotech Pulse: Pfizer's Xeljanz Gets EU Nod, NewLink Losses Narrow, Neuralstem Commences Stroke Drug Trial",2018-08-01 09:01:00-04:00,RDUS,negative
1072905.0,"Stocks Which Set New 52-Week Low Yesterday, July 30th",2018-07-31 09:25:00-04:00,RDUS,negative
1072906.0,"Stocks Which Set New 52-Week Low Friday, July 27",2018-07-30 12:17:00-04:00,RDUS,negative
1072907.0,7 Stocks Moving In Tuesday's After-Hours Session,2018-07-24 16:54:00-04:00,RDUS,neutral
1072908.0,Radius Health Offers Update On Appeal Of CHMP Opinion For Abaloparatide-SC: CHMP Communicated Negative Trend Vote For Co.'s Marketing Authorization Application For Abaloparatide-SC For Osteporosis,2018-07-24 16:21:00-04:00,RDUS,negative
1072909.0,"Radius Health 10%+ Owner BB BIOTECH AG  Buys 40,000 @ Avg Price: $28.91",2018-05-24 14:32:00-04:00,RDUS,neutral
1072910.0,"Radius Health Q1 EPS $(1.37) Beats $(1.46) Estimate, Sales $14.547M Beat $13.9M Estimate",2018-05-10 07:33:00-04:00,RDUS,neutral
1072911.0,What's In Store For Radius Health In Q1 Earnings?,2018-05-07 13:56:00-04:00,RDUS,neutral
1072912.0,"Insider Buys Of The Week: Intercept Pharmaceuticals, Macy's And More",2018-04-15 18:05:00-04:00,RDUS,neutral
1072913.0,"Radius Health, Inc.: BB BIOTECH AG (10%+) Buys 50,000 @ Avg Price: $36.58 (Form4)",2018-04-09 13:23:00-04:00,RDUS,neutral
1072914.0,Radius Health Spikes to High of $36.70 on Insider Buy,2018-04-09 13:22:00-04:00,RDUS,neutral
1072915.0,Radius Health On Friday Initiated Phase 3 Clinical Trial Of Abaloparatide Injection For Treatment Of Male Osteoporosis,2018-04-02 09:40:00-04:00,RDUS,neutral
1072916.0,Leerink's Takeaways From CNBC's 'Healthy Returns' Conference,2018-03-31 08:59:00-04:00,RDUS,positive
1072917.0,36 Stocks Moving In Thursday's Mid-Day Session,2018-03-29 12:21:00-04:00,RDUS,neutral
1072918.0,"Benzinga's Top Upgrades, Downgrades For March 29, 2018",2018-03-29 09:41:00-04:00,RDUS,positive
1072919.0,"Leerink Swann Initiates Coverage On Radius Health with Outperform Rating, Announces $53.00 Price Target",2018-03-29 07:35:00-04:00,RDUS,neutral
1072920.0,Radius Health Offers Update On CHMP Opinino For Abaloparatide-SC: Negative Trend Vote On Benefit-Risk Balance Communicated,2018-03-22 09:01:00-04:00,RDUS,negative
1072921.0,Radius Health Presents Positive Data for the ACTIVExtend BMD Responder Analysis for TYMLOS Injection at #ENDO2018,2018-03-17 15:34:00-04:00,RDUS,positive
1072922.0,42 Biggest Movers From Friday,2018-03-05 05:08:00-05:00,RDUS,neutral
1072923.0,"Radius Health Shares Down 14.5% After CO. Reported Late Thursday Q4 EPS $(1.59) vs $(1.44) Est., Beat On Revenue",2018-03-02 14:06:00-05:00,RDUS,positive
1072924.0,32 Stocks Moving In Friday's Mid-Day Session,2018-03-02 12:20:00-05:00,RDUS,neutral
1072925.0,"Morgan Stanley Maintains Overweight on Radius Health, Raises Price Target to $61.00",2018-03-02 09:02:00-05:00,RDUS,negative
1072926.0,"Jim Cramer Weighs In On Albemarle, Square And More",2018-03-02 07:13:00-05:00,RDUS,neutral
1072927.0,"Radius Health Reports Q4 EPS $(1.22) vs $(1.44) Est., Sales $7.66M vs $7.03M Est.",2018-03-01 16:56:00-05:00,RDUS,neutral
1072928.0,"Radius Health Reports Q4 EPS $(1.59) Vs $(1.44) Est., Sales $7.6M vs $7M Est.",2018-03-01 16:05:00-05:00,RDUS,neutral
1072929.0,"JP Morgan Maintains Overweight on Radius Health, Lowers price target to $60.00",2018-02-12 08:08:00-05:00,RDUS,negative
1072930.0,35 Stocks Moving In Monday's Mid-Day Session,2018-01-29 12:21:00-05:00,RDUS,neutral
1072931.0,"Analyst: Radius Health Could Advance 50% With Osteoporosis Treatment, Breast Cancer Pipeline",2018-01-29 11:50:00-05:00,RDUS,negative
1072932.0,"Benzinga's Top Upgrades, Downgrades For January 29, 2018",2018-01-29 09:19:00-05:00,RDUS,positive
1072933.0,"Morgan Stanley Initiates Coverage On Radius Health with Overweight Rating, Announces $57.00 Price Target",2018-01-29 07:17:00-05:00,RDUS,negative
1072934.0,Radius Health Reports CHMP Will Issue Third-Day 180-List Of Outstanding Issues In Regulatory Review Of Abaloparatide-SC,2017-12-15 07:32:00-05:00,RDUS,positive
1072935.0,36 Biggest Movers From Friday,2017-12-11 06:02:00-05:00,RDUS,neutral
1072936.0,25 Stocks Moving In Friday's Mid-Day Session,2017-12-08 12:01:00-05:00,RDUS,neutral
1072937.0,"Radius Health Shares Up 4% In Fri. Pre-Market Session; Late Thurs., Co. Announced RAD1901 Continued To Show Promise In Advanced ER+ / HER2- Breast Cancer",2017-12-08 08:54:00-05:00,RDUS,neutral
1072938.0,"Radius Health 10%+ Owner BB BIOTECH AG (10%+) Buys 50,000 @ Avg Price: $26.25 Form4",2017-11-16 12:19:00-05:00,RDUS,neutral
1072939.0,"Radius Health 10%+ Owner BB BIOTECH AG  Buys 50,000 @ Avg Price: $29.15 -Form4",2017-11-07 12:46:00-05:00,RDUS,neutral
1072940.0,"Radius Health Reports Q3 EPS $(1.31) vs $(1.26 ) Est., Sales $13.469M vs $6.75M Est.",2017-11-02 16:39:00-04:00,RDUS,neutral
1072941.0,"BB BIOTECH AG  Buys 50,000 @ Avg Price: $30.95 -Form4",2017-10-27 15:41:00-04:00,RDUS,neutral
1072942.0,Radius Health Receives FDA Fast Track Designation for Elacestrant,2017-10-18 09:02:00-04:00,RDUS,neutral
1072943.0,"Wall Street's M&A Chatter From October 13-15: T-Mobile-Sprint, Radius Health, ANI Pharmaceuticals",2017-10-16 07:40:00-04:00,RDUS,neutral
1072944.0,Radius Health Shares Spike ~$1.10 Over Last Min. As Traders Circulate Takeover Chatter Via Chatroom,2017-10-13 10:07:00-04:00,RDUS,positive
1072945.0,Radius Health Starts Phase 1 Clinical Trial of RAD140,2017-09-29 08:50:00-04:00,RDUS,neutral
1072946.0,Radius Health Presents Positive Data for TYMLOS  Injection from the ACTIVExtend Trial at ASBMR 2017,2017-09-10 17:33:00-04:00,RDUS,positive
1072947.0,"Radius Health 10%+ Owner BB BIOTECH AG  Buys 50,000 @ Avg Price: $36.75 -Form4",2017-09-07 14:00:00-04:00,RDUS,neutral
1072948.0,"Radius Health I0% + Owner BB Biotech Buys 60,000 @ $35.97/Share -Form 4",2017-08-18 11:44:00-04:00,RDUS,neutral
1072949.0,20 Stocks Moving In Thursday's Pre-Market Session,2017-08-17 08:05:00-04:00,RDUS,neutral
1072950.0,Form 4 From Radius Health Shows Purchase Of 150K Shares By 10% Owner Biotech Growth NV,2017-08-11 11:18:00-04:00,RDUS,positive
1072951.0,Watch These 5 Huge Put Purchases In Monday Trade,2017-08-07 04:45:00-04:00,RDUS,positive
1072952.0,Benzinga's Option Alert Recap From August 4,2017-08-04 16:23:00-04:00,RDUS,positive
1072953.0,Radius Health Option Alert: Aug 18 $35 Puts Sweep (2) at the Ask: 2000 @ $0.49 vs 503 OI; Ref=$40.92,2017-08-04 12:51:00-04:00,RDUS,positive
1072954.0,"Radius Health Reports Q2 EPS $(1.58) vs $(1.23) Est., Sales $980K vs $1.37M Est.",2017-08-03 16:49:00-04:00,RDUS,neutral
1072955.0,Radius Health Shares Spiek To High Of $44.40 After Express Scripts 2018 Preferred Formulary Release Shows Radius Drug Tymlos Is Preferred Formulary vs. Forteo,2017-07-31 09:34:00-04:00,RDUS,positive
1072956.0,The Market In 5 Minutes,2017-07-24 09:02:00-04:00,RDUS,neutral
1072957.0,Apparently Fake Press Release Roils Radius Health Investors,2017-07-21 16:39:00-04:00,RDUS,negative
1072958.0,"Dubious Radius Health Press Release Circulating On Twitter Features Conf. Call ID; Upon Calling Conf. Dial-In Number, Benzinga Was Informed That Conf. Call ID Refers To Call That Occurred May 24th",2017-07-21 16:14:00-04:00,RDUS,negative
1072960.0,"UPDATE: Apparent/Potentially Fake Radius Health Press Release Cannot Be Found In GlobeNewswire Release Feed, Includes Numerous Grammatical Errors, Odd Language; When Benzinga Reached Out To Co., Receptionist Said She Hadn't Heard About Call Tonight",2017-07-21 16:02:00-04:00,RDUS,negative
1072961.0,"Radius Health Shares Up ~10% From Session Lows As Traders Circulate Potentially Fake GlobeNewswire Release From Co Suggesting Will Hold Conference Call Tonight, Stock is ~28% Short",2017-07-21 16:02:00-04:00,RDUS,negative
1072962.0,Radius Health Spikes to High of $43 on Volume,2017-07-21 15:00:00-04:00,RDUS,neutral
1072963.0,A Peek Into The Markets: U.S. Stock Futures Edge Higher; Netflix Earnings In Focus,2017-07-17 07:35:00-04:00,RDUS,neutral
1072964.0,Radius health Announces Jesper Hoiland President and CEO,2017-07-17 07:07:00-04:00,RDUS,neutral
1072965.0,"Radius Health to Collaborate with Teijin Limited, Radius to Receive Upfront and Milestone Payments",2017-07-13 07:43:00-04:00,RDUS,negative
1072966.0,Radius Presents Positive Data From A Fully Enrolled Ongoing Phase I Study for Investigational Drug Elacestrant #ASCO17,2017-06-04 09:13:00-04:00,RDUS,positive
1072967.0,Radius Health Reports Top-Line Results from Completed ACTIVExtend Study for TYMLOS in Postmenopausal Women with Osteoporosis: Showed Sustained Statistically Significant Fracture Risk Reduction,2017-05-24 16:01:00-04:00,RDUS,negative
1072968.0,The Current State Of The Breast Cancer Treatment Space,2017-05-23 08:59:00-04:00,RDUS,negative
1072969.0,"Radius Health 10%+ Owner BB BIOTECH AG Buys 50,000 @ Avg Price: $34.41 -Form4",2017-05-22 14:54:00-04:00,RDUS,neutral
1072970.0,15 Biggest Mid-Day Gainers For Monday,2017-05-22 12:32:00-04:00,RDUS,neutral
1072971.0,Amgen News Has Major Readthrough For Radius Health,2017-05-22 09:43:00-04:00,RDUS,neutral
1072972.0,"Radius Health Shares Up 15% Premarket, Likely on the Heels of Concerning Adverse Side Effect Data from Amgen on Its Osteoporosis Treatment;  BZ NOTE: Radius' Competing Product to Amgen's Evenity is Called Tymlos",2017-05-22 09:12:00-04:00,RDUS,positive
1072973.0,22 Stocks Moving In Monday's Pre-Market Session,2017-05-22 08:07:00-04:00,RDUS,neutral
1072974.0,"Radius Health 10%+ Owner BB Biotech AG Buys 15,000 Shares @ Avg Price: $34.00 -Form 4",2017-05-16 11:43:00-04:00,RDUS,positive
1072975.0,Radius Health Announces Jose Carmona CFO,2017-05-15 07:14:00-04:00,RDUS,neutral
1072976.0,"Radius Health 10%+ Owner BB Biotech AG Buys 50,000 Shares @ Avg Price: $35.93 -Form 4",2017-05-11 14:54:00-04:00,RDUS,positive
1072977.0,BB Biotech Reports 75K Share Buy in Radius Health @$33.91 -Form 4,2017-05-03 15:15:00-04:00,RDUS,positive
1072978.0,BB Biotech Reports 150K Share Buy in Radius Health @$35.39 -Form 4,2017-05-02 13:41:00-04:00,RDUS,positive
1072979.0,"Benzinga's Top Upgrades, Downgrades For May 2, 2017",2017-05-02 09:21:00-04:00,RDUS,positive
1072980.0,Cowen & Co. Downgrades Radius Health to Market Perform,2017-05-02 07:14:00-04:00,RDUS,neutral
1072981.0,Radius Health Q1 EPS $(1.32) vs $(1.18) Est,2017-05-01 06:35:00-04:00,RDUS,neutral
1072982.0,"PR Confirms FDA Approves Radius Health's TYMLOS, Expects Commercial Launch In May",2017-04-28 10:44:00-04:00,RDUS,positive
1072983.0,FDA Approves Radius health Drug Injectable Tymlos,2017-04-28 10:05:00-04:00,RDUS,positive
1072984.0,25 Stocks Moving In Wednesday's Pre-Market Session,2017-04-05 08:12:00-04:00,RDUS,neutral
1072985.0,"H.C. Wainwright Reiterates Buy On Radius Health, Lowers Price Target To $66",2017-03-24 07:05:00-04:00,RDUS,negative
1072986.0,Benzinga's Option Alert Recap From March 13,2017-03-14 06:50:00-04:00,RDUS,positive
1072987.0,"Option Alert: Radius Health Jul. $30 Puts at the Ask: Volume of 2,000 at $3.701 vs Open Interest 410",2017-03-13 10:20:00-04:00,RDUS,positive
1072988.0,Cantor Fitzgerald Reiterates Buy Rating On Radius Health And $65 Price Target,2017-03-10 11:08:00-05:00,RDUS,neutral
1072989.0,"Radius Health Shares Ticking Slightly Lower Despite Hearing JP Morgan Defending Name, Still Sees Approval",2017-03-10 10:24:00-05:00,RDUS,positive
1072990.0,Radius Health Receives Notification of PDUFA Extension for Abaloparatide-SC,2017-03-10 09:21:00-05:00,RDUS,neutral
1072991.0,Here's Your March PDUFA Date Preview,2017-03-08 14:59:00-05:00,RDUS,neutral
1072992.0,Radius Health Reports Q4 EPS $(1.22) vs $(1.34) Est.,2017-02-23 16:18:00-05:00,RDUS,neutral
1072993.0,"BZ NOTE on Radius Health Unconfirmed Chatter: TheStreet's Adam Feuerstein Threw Cold Water on This Rumor in Oct. 2016, Saying 'if $RDUS on verge of takeout, why did MPM (board seat) distribute 2m shares of co. to its investors?'",2017-02-15 12:00:00-05:00,RDUS,positive
1072994.0,"Radius Health Shares Now Up 3.2% Following Unconfirmed, Rehashed Takeover Chatter; Trader Showing Skepticism on Likelihood of Deal, Says Shire Takoever Would Not Make 'Much Sense'",2017-02-15 11:59:00-05:00,RDUS,negative
1072995.0,Hearing Shire Still Remains Interested In Radius,2017-02-15 11:47:00-05:00,RDUS,positive
1072996.0,Radius Shares Spike To High Of $47.11/Share,2017-02-15 11:46:00-05:00,RDUS,positive
1072997.0,Hearing Betaville Reports Shire Looking At Radius Pharma,2017-01-09 09:51:00-05:00,RDUS,neutral
1072998.0,Watch These 7 Huge Put Purchases In Monday Trade,2016-12-19 04:25:00-05:00,RDUS,positive
1072999.0,Watch These 5 Huge Put Purchases In Thursday Trade,2016-12-15 04:25:00-05:00,RDUS,positive
1073000.0,Option Alert: RDUS Dec16 40.0 Puts Sweep: 588 @  ASK  $1.60: 598 traded vs 2720 OI:  Earnings 2/23 Before Open (est)  $40.90 Ref,2016-12-14 10:57:00-05:00,RDUS,positive
1073001.0,Radius Health Shares Down 17.75% On Heavy Volume; Hearing Cantor Fitzgerald Out Saying Positive Clinical Data Reported Today Did Not Meet Expectations,2016-12-08 12:49:00-05:00,RDUS,positive
1073002.0,"Radius Presents Positive Phase I Data for Investigational Drug RAD1901, Says 3 Patients Had Confirmed Partial Responses By RECIST Criteria",2016-12-08 08:47:00-05:00,RDUS,positive
1073003.0,"Radius Health Q3 EPS $(1.07) vs $(1.03) Est, No Revenue",2016-11-03 06:33:00-04:00,RDUS,negative
1073004.0,Radius Health Sells off to Low of $38.35 on Volume,2016-11-02 14:12:00-04:00,RDUS,negative
1073005.0,"BZ NOTE: TheStreet's Adam Feuerstein Tweeted on Radius Health On Oct. 12: 'if $RDUS on verge of takeout, why did MPM (board seat) distribute 2m shares of co. to its investors? SEC filing.'",2016-10-14 14:41:00-04:00,RDUS,positive
1073006.0,Hearing Shire For Radius Takeout Rumors,2016-10-14 14:33:00-04:00,RDUS,neutral
1073007.0,14 Stocks Moving In Tuesday's Pre-Market Session,2016-10-11 08:33:00-04:00,RDUS,neutral
1073008.0,15 Stocks Moving In Monday's Pre-Market Session,2016-09-19 08:25:00-04:00,RDUS,neutral
1073009.0,18 Stocks Moving In Friday's Pre-Market Session,2016-08-19 08:22:00-04:00,RDUS,neutral
1073010.0,JAMA Releases Positive Phase 3 Data for Abaloparatide in Postmenopausal Women With Osteoporosis,2016-08-16 11:02:00-04:00,RDUS,positive
1073011.0,Thursday Morning's Top Earnings Reports,2016-08-04 09:56:00-04:00,RDUS,positive
1073012.0,Radius Health Reports Q2 EPS $(1.01) vs $(0.95) Est.,2016-08-04 06:38:00-04:00,RDUS,neutral
1073013.0,Benzinga's Volume Movers,2016-08-03 10:38:00-04:00,RDUS,neutral
1073014.0,Radius Health Volume Spike,2016-08-02 14:22:00-04:00,RDUS,neutral
1073015.0,Radius Reveals FDA Acceptance For Filing Of NDA For Abaloparatide-SC For Treatment Of Postmenopausal Women With Osteoporosis,2016-05-31 15:05:00-04:00,RDUS,positive
1073016.0,Radius Reports FDA Acceptance Of NDA For Adaloparatide-SC For Postmenopusal Osteoporosis,2016-05-31 14:01:00-04:00,RDUS,positive
1073017.0,"H.C. Wainwright Initiates Radius Health At Buy, $55 Target",2016-05-23 10:11:00-04:00,RDUS,neutral
1073018.0,Benzinga's Top Initiations,2016-05-23 09:53:00-04:00,RDUS,positive
1073019.0,The Market In 5 Minutes: Merger Monday Mania,2016-05-23 08:58:00-04:00,RDUS,neutral
1073020.0,"HC Wainwright Initiates Coverage on Radius Health at Buy, Announces $55.00 PT",2016-05-23 07:38:00-04:00,RDUS,neutral
1073021.0,Cowen & Company Assumes Radius Health at Outperform,2016-05-06 09:39:00-04:00,RDUS,neutral
1073022.0,Radius Health Q1 EPS ($0.94) vs ($0.74) est,2016-05-05 06:56:00-04:00,RDUS,neutral
1073023.0,Editas Medicine and Radius Health Choose Mass Innovation Labs for Rapid Start and Operational Capabilities,2016-05-03 09:00:00-04:00,RDUS,positive
1073024.0,Radius Health's Overhangs Were Just Removed: Buy Time,2016-03-31 14:24:00-04:00,RDUS,neutral
1073025.0,Radius Health Submits NDA to the FDA for Abaloparatide-SC for the Treatment of Postmenopausal Women with Osteoporosis,2016-03-30 15:18:00-04:00,RDUS,neutral
1073026.0,"Goldman Sachs Initiates Coverage on Radius Health at Neutral, Announces $37.00 PT",2016-03-30 06:52:00-04:00,RDUS,neutral
1073027.0,Radius Health Reports Q4 EPS $(0.77) vs $(0.64) Est.,2016-02-25 06:45:00-05:00,RDUS,neutral
1073028.0,Why Did Jefferies Downgrade Radius Health?,2016-02-24 10:12:00-05:00,RDUS,neutral
1073029.0,Benzinga's Top Downgrades,2016-02-24 09:15:00-05:00,RDUS,positive
1073030.0,"Jefferies Downgrades Radius Health to Hold, Maintains $37.00 PT",2016-02-24 07:25:00-05:00,RDUS,neutral
1073031.0,Benzinga's Volume Movers,2016-02-22 10:16:00-05:00,RDUS,neutral
1073032.0,"Radius Health Shares Up 29% Following Data from Amgen, UCB's Romosozumab Showing Failed Achievement on One of Two Secondary Endpoints",2016-02-22 09:52:00-05:00,RDUS,negative
1073033.0,10 Stocks Moving In Monday's Pre-Market Session,2016-02-22 08:26:00-05:00,RDUS,neutral
1073034.0,Radius Health Shares Falling,2016-02-03 10:15:00-05:00,RDUS,positive
1073035.0,"Radius Health Shares Spiking Higher Into The Close, Conf. Call For RAD1901 Clinical Collaboration At 430PM",2016-01-28 15:40:00-05:00,RDUS,positive
1073036.0,"Radius Health, Novartis Pharma. Partner To Evaluate RAD1901 Combo In Advanced Breast Cancer Regimens",2016-01-27 16:32:00-05:00,RDUS,negative
1073037.0,Radius Health Appoints Former GlaxoSmithKline CEO Jean-Pierre Garnier to Board of Directors,2015-12-07 16:02:00-05:00,RDUS,neutral
1073038.0,Radius Announces European Medicines Agency Validates Marketing Authorization Application for Abaloparatide-SC for the Treatment of Osteoporosis in Postmenopausal Women,2015-12-04 16:46:00-05:00,RDUS,positive
1073039.0,Hearing Renewed Takeover Chatter in Radius Health,2015-12-02 12:35:00-05:00,RDUS,neutral
1073040.0,Radius Health Shares Spiking,2015-12-02 12:31:00-05:00,RDUS,positive
1073041.0,Radius Health Has Submitted a Marketing Authorization Application for the Investigational Drug Abaloparatide-SC for the Treatment of Postmenopausal Osteoporosis in Europe,2015-11-17 08:32:00-05:00,RDUS,neutral
1073042.0,Radius Health Shares Sell Off to Low,2015-11-16 13:43:00-05:00,RDUS,neutral
1073043.0,Radius Health Reports Q3 EPS $(0.68) vs. Est. $(0.57),2015-11-05 07:05:00-05:00,RDUS,neutral
1073044.0,Here's Why Biotechs Fell On Monday,2015-10-19 16:29:00-04:00,RDUS,neutral
1073045.0,"Benzinga's M&A Chatter for Thursday October 15, 2015",2015-10-15 18:29:00-04:00,RDUS,neutral
1073046.0,Cowen Analyst Thinks Shire-Radius Health Merger Is Unlikely After Visit With CEO,2015-10-15 17:53:00-04:00,RDUS,neutral
1073047.0,"UPDATE: Cowen Analyst Says Shire-Radius Rumor Unlikely, Mentions That Shire Has Been Rumored In A Couple Deals And That Radius Health CEO Had Just Left Cowen Office Prior To Benzinga Phone Call",2015-10-15 13:13:00-04:00,RDUS,neutral
1073048.0,Shire May Bid for Radius Health -Proactive Investors,2015-10-15 12:11:00-04:00,RDUS,positive
1073049.0,Radius Health Announces Positive Phase 3 Data from ACTIVExtend Trial at ASBMR,2015-10-12 14:36:00-04:00,RDUS,positive
1073050.0,Morning Market Gainers,2015-10-12 09:43:00-04:00,RDUS,neutral
1073051.0,Benzinga's Top #PreMarket Gainers,2015-10-12 08:15:00-04:00,RDUS,positive
1073052.0,Radius Health Presents Positive Phase 3 Top-Line Data for Investigational Osteoporosis Therapy Abaloparatide at ASBMR,2015-10-11 00:07:00-04:00,RDUS,positive
1073053.0,Radius Health Names David Snow Chief Commercial Officer,2015-09-09 16:01:00-04:00,RDUS,neutral
1073054.0,"Biotech Growth NV Buys 100,000 Radius Health @$64.00/Share -Form 4",2015-08-24 15:34:00-04:00,RDUS,positive
1073055.0,Benzinga's Top Initiations,2015-08-14 10:12:00-04:00,RDUS,positive
1073056.0,"Deutsche Bank Initiates Coverage on Radius Health at Buy, Announces $90.00 PT",2015-08-14 07:39:00-04:00,RDUS,neutral
1073057.0,Radius Health Q2 EPS -$0.61 vs -$0.52 est,2015-08-06 06:10:00-04:00,RDUS,neutral
1073058.0,Radius Health Announces That it Has Hired Dr. Lorraine Fitzpatrick As Chief Medical Officer,2015-07-27 17:31:00-04:00,RDUS,neutral
1073059.0,Radius Health Prices ~4.05M Share Offering @$74.00/Share,2015-07-22 20:28:00-04:00,RDUS,positive
1073060.0,Morning Market Losers,2015-07-22 09:58:00-04:00,RDUS,negative
1073061.0,"Shares of Radius Health Trading Down 9%; 8-K Filing from Co. Last Night Showed In July '15 FDA Denied Re-Submitted Request for Breakthrough Designation for Abaloparatide-SC, Says Evaluating Options for Another Resubmission",2015-07-22 09:29:00-04:00,RDUS,negative
1073062.0,Benzinga's Top #PreMarket Losers,2015-07-22 08:28:00-04:00,RDUS,negative
1073063.0,"Radius Health Announced That it Has Appointed Debasish Roychowdhury, MD, to Its Board of Directors and the Formation of the Radius Oncology Clinical Advisory Board (OCAB)",2015-07-20 07:15:00-04:00,RDUS,neutral
1073064.0,Radius Health Announces Preclinical Data for RAD1901 in Combination With CDK and mTOR Inhibitors,2015-07-15 20:24:00-04:00,RDUS,negative
1073065.0,Did Anyone Notice Sucampo's Breakout?,2015-07-13 15:09:00-04:00,RDUS,neutral
1073066.0,Maxim Group Downgrades Radius Health to Hold,2015-06-22 07:27:00-04:00,RDUS,neutral
1073067.0,"Daily Movers: Welcoming Fitbit; BioMarin Soars Again, While Oracle Slumps",2015-06-18 16:21:00-04:00,RDUS,positive
1073068.0,Mid-Afternoon Market Update: BioMarin Pharmaceutical Jumps Following Announcement Of Positive BMN 111 Data; Jabil Circuit Shares Fall,2015-06-18 15:32:00-04:00,RDUS,positive
1073069.0,Mid-Day Market Update: Oracle Drops On Downbeat Results; Radius Health Shares Surge,2015-06-18 13:31:00-04:00,RDUS,positive
1073070.0,Mid-Morning Market Update: Markets Open Higher; Kroger Earnings Beat Views,2015-06-18 10:22:00-04:00,RDUS,neutral
1073071.0,Benzinga's Volume Movers,2015-06-18 10:21:00-04:00,RDUS,neutral
1073072.0,Stocks Hitting 52-Week Highs,2015-06-18 10:10:00-04:00,RDUS,neutral
1073073.0,Morning Market Gainers,2015-06-18 09:39:00-04:00,RDUS,neutral
1073074.0,Radius Announces Positive Top-Line Data from ACTIVExtend Trial,2015-06-18 04:28:00-04:00,RDUS,positive
1073075.0,Radius Health Announces Engagement With Myrtle Potter & Company for Development of Abaloparatide Commercialization Strategy,2015-06-01 07:02:00-04:00,RDUS,positive
1073076.0,"General Electric, Tyco And Others Insiders Have Been Buying",2015-05-06 16:11:00-04:00,RDUS,neutral
1073077.0,Radius Q1 EPS -$0.47 vs -$0.52 est,2015-05-06 06:45:00-04:00,RDUS,neutral
1073078.0,Benzinga's Top Initiations,2015-04-24 09:58:00-04:00,RDUS,positive
1073079.0,Maxim Group Initiates Radius Health At Buy,2015-04-24 09:15:00-04:00,RDUS,neutral
1073080.0,"Maxim Group Initiates Coverage on Radius Health at Buy, Announces $50.00 PT",2015-04-24 08:40:00-04:00,RDUS,neutral
1073081.0,"Radius Health Names Brent Hatzis-Schoch SVP, General Counsel",2015-04-10 08:02:00-04:00,RDUS,neutral
1073082.0,"Earnings Scheduled For March 10, 2015",2015-03-10 05:38:00-04:00,RDUS,neutral
1073083.0,"Radius Health Shareholder Biotech Growth Buys 75,000 Shares @$47.08/Share -Form 4",2015-03-09 16:38:00-04:00,RDUS,positive
1073084.0,"Biotech Growth NV Buys 35,000 Shares of Radius Health @$45.74/Share -Form 4",2015-02-27 12:10:00-05:00,RDUS,positive
1073085.0,"Bank of America Initiates Coverage on Radius Health at Buy, Announces $60.00 PT",2015-02-02 06:35:00-05:00,RDUS,neutral
1073086.0,Radius Health Announces Oral Presentation of the ACTIVE Phase 3 Clinical Trial of Abaloparatide-SC,2015-01-29 08:04:00-05:00,RDUS,positive
1073087.0,Benzinga's Volume Movers,2015-01-23 10:34:00-05:00,RDUS,neutral
1073088.0,Radius Health Prices 4M Share Offering @$36.75/Share,2015-01-23 04:36:00-05:00,RDUS,positive
1073089.0,Radius Health Announces 3.5M Share Proposed Public Offering,2015-01-20 17:46:00-05:00,RDUS,positive
1073090.0,Radius Health Reports Proposed Offering Of 3.5M Shares,2015-01-20 17:40:00-05:00,RDUS,positive
1073091.0,Radius Announces Positive Follow Up Data From Phase 3 Results,2015-01-12 07:18:00-05:00,RDUS,positive
1073092.0,The Top IPO Of 2014,2014-12-30 14:20:00-05:00,RDUS,positive
1073093.0,"Mid-Day Gainers From December 22: Chinanet, Radius Health, DryShips And More",2014-12-22 13:01:00-05:00,RDUS,neutral
1073094.0,Benzinga's Volume Movers,2014-12-22 10:47:00-05:00,RDUS,neutral
1073095.0,Radius Health Shares Rise 15% Following Report of Phase 3 Trial Primary Endpoint Met,2014-12-22 10:42:00-05:00,RDUS,positive
1073096.0,Radius Phase 3 Abaloparatide-SC Study in Postmenopausal Women With Severe Osteoporosis Meets Primary Endpoint,2014-12-22 05:13:00-05:00,RDUS,negative
1073097.0,FDA Accepts IND Application For Radius Health's Investigational Drug RAD1901,2014-12-19 10:07:00-05:00,RDUS,positive
1073098.0,The Journal of Clinical Endocrinology & Metabolism Publishes Radius Health's Phase II Study Of The Investigational Drug Abaloparatide In Postmenopausal Women With Osteoporosis,2014-11-24 08:22:00-05:00,RDUS,neutral
1073099.0,1 Way To Search For The 'Next Big Thing' In Biotech,2014-11-13 15:13:00-05:00,RDUS,neutral
1073100.0,Radius Health Reports Q3 EPS of $(0.59) vs $(0.65) Est,2014-11-10 17:22:00-05:00,RDUS,neutral
1073101.0,Radius Health Prices 2.75M Shares at $18.25/Share,2014-10-02 08:40:00-04:00,RDUS,positive
1073102.0,Radius Health Reports Offering of Common Stock,2014-10-01 16:01:00-04:00,RDUS,neutral
1073103.0,Filing from Radius Health Shows Registration for $150M Mixed Securities Shelf Offering,2014-09-02 16:33:00-04:00,RDUS,positive
1073104.0,Radius Health Reports Q2 EPS of $(2.22) vs $(0.89) Est; Revenue of $12.60M,2014-08-12 07:32:00-04:00,RDUS,neutral
1073105.0,Upcoming Corporate Events/Presentations for the Week of Aug. 11-15th,2014-08-11 11:54:00-04:00,RDUS,neutral
1073106.0,"Analysts Come Out Bullish On Radius Health, Shares Rally",2014-07-16 11:29:00-04:00,RDUS,positive
1073107.0,Benzinga's Top Initiations,2014-07-16 09:11:00-04:00,RDUS,positive
1073108.0,Canaccord Genuity Initiates Radius Health At Buy,2014-07-16 07:43:00-04:00,RDUS,neutral
1073109.0,Cowen & Company Initiates Coverage on Radius Health at Outperform,2014-07-16 07:43:00-04:00,RDUS,neutral
1073110.0,"Cantor Fitzgerald Initiates Coverage on Radius Health at Buy, Announces $20.00 PT",2014-07-16 07:42:00-04:00,RDUS,neutral
1073111.0,"Jefferies Initiates Coverage on Radius Health at Buy, Announces $17.00 PT",2014-07-16 06:35:00-04:00,RDUS,neutral
1073112.0,"Canaccord Genuity Initiates Coverage on Radius Health at Buy, Announces $21.00 PT",2014-07-16 06:35:00-04:00,RDUS,neutral
1073113.0,"Radius Health Shareholder F2 Bioscience IV LP Buys 587,500 Shares @$8.00/Share -Form 4",2014-06-13 16:20:00-04:00,RDUS,positive
1073114.0," Radius Health Director Jovan-Embiricos Buys 587,500 Shares @$8.00/Share -Form 4",2014-06-13 10:15:00-04:00,RDUS,positive
1073115.0,"Shares of Radius Health Have Opened for Trade at $8.03/Share, Priced at $8",2014-06-06 10:58:00-04:00,RDUS,positive
1073116.0,Waiting on Three IPOs This Morning,2014-06-06 07:46:00-04:00,RDUS,neutral
1073117.0,"Economic and IPO Calendar for Friday June 6, 2014",2014-06-06 05:53:00-04:00,RDUS,neutral
1073118.0,Radius Health Prices 6.5M Share IPO at $8.00/Share ,2014-06-05 19:48:00-04:00,RDUS,positive
1073119.0,Radius Health Sees 6.5M Share IPO Priced at $8/Share,2014-06-02 13:57:00-04:00,RDUS,positive
1073120.0,"IPO Lookout For The Week Of May 5: Alder Biopharma, Cheetah Mobile, GasLog Partners",2014-05-05 09:45:00-04:00,RDUS,neutral
1073121.0,Radius Health 5M Share IPO Expected at $14-$16/Share,2014-04-25 06:27:00-04:00,RDUS,positive
